Cargando…

Intestinal microbiota in functional bowel disorders: a Rome foundation report

It is increasingly perceived that gut host–microbial interactions are important elements in the pathogenesis of functional gastrointestinal disorders (FGID). The most convincing evidence to date is the finding that functional dyspepsia and irritable bowel syndrome (IBS) may develop in predisposed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simrén, Magnus, Barbara, Giovanni, Flint, Harry J, Spiegel, Brennan M R, Spiller, Robin C, Vanner, Stephen, Verdu, Elena F, Whorwell, Peter J, Zoetendal, Erwin G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2013
Materias:	Recent Advances in Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551212/ https://www.ncbi.nlm.nih.gov/pubmed/22730468 http://dx.doi.org/10.1136/gutjnl-2012-302167

Ejemplares similares

The gut microbiota and host health: a new clinical frontier
por: Marchesi, Julian R, et al.
Publicado: (2016)

Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease
por: Rimola, Jordi, et al.
Publicado: (2022)

Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments
por: Gottlieb, Klaus, et al.
Publicado: (2021)

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
por: Lin, Simeng, et al.
Publicado: (2022)

Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review
por: Bettenworth, Dominik, et al.
Publicado: (2019)

Gut microbiota-derived metabolites as central regulators in metabolic disorders
por: Agus, Allison, et al.
Publicado: (2021)

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
por: Ting, Nick Lung-Ngai, et al.
Publicado: (2022)

Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management
por: Leung, T.F, et al.
Publicado: (2003)

Applications of dual energy CT in clinical practice: A pictorial essay
por: Sanghavi, Parang S, et al.
Publicado: (2019)

MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis –18 month's follow-up of 12 cases
por: Dev, Bhawna, et al.
Publicado: (2019)

Mechanisms of rhinovirus-induced asthma
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2004)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Symptomatic reflux disease: the present, the past and the future
por: Boeckxstaens, Guy, et al.
Publicado: (2014)

Expert opinions and scientific evidence for colonoscopy key performance indicators
por: Rees, Colin J, et al.
Publicado: (2016)

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
por: Lawler, Mark, et al.
Publicado: (2018)

Modern diagnosis of GERD: the Lyon Consensus
por: Gyawali, C Prakash, et al.
Publicado: (2018)

Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
por: Waldman, Scott A, et al.
Publicado: (2018)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Machine learning in GI endoscopy: practical guidance in how to interpret a novel field
por: van der Sommen, Fons, et al.
Publicado: (2020)

Big data in IBD: big progress for clinical practice
por: Seyed Tabib, Nasim Sadat, et al.
Publicado: (2020)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
por: Dufour, Jean-François, et al.
Publicado: (2020)

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
por: Chapelle, Nicolas, et al.
Publicado: (2020)

Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management
por: Misselwitz, Benjamin, et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
por: Pinter, Matthias, et al.
Publicado: (2021)

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
por: Urban, Stephan, et al.
Publicado: (2021)

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
por: van Baar, Annieke C G, et al.
Publicado: (2021)

Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022)

Understanding the role of the gut in undernutrition: what can technology tell us?
por: Thompson, Alex J, et al.
Publicado: (2021)

Current therapies and new developments in NASH
por: Dufour, Jean-François, et al.
Publicado: (2022)

Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
por: Vanuytsel, Tim, et al.
Publicado: (2023)

SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
por: Luxenburger, Hendrik, et al.
Publicado: (2023)

Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
por: Marjot, Thomas, et al.
Publicado: (2023)

Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice
por: Simren, Magnus, et al.
Publicado: (2017)

Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
por: Adolph, Timon E, et al.
Publicado: (2022)

The role of gut microbiota in cancer treatment: friend or foe?
por: Cheng, Wing Yin, et al.
Publicado: (2020)

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
por: Frändemark, Åsa, et al.
Publicado: (2023)

Mucus barrier, mucins and gut microbiota: the expected slimy partners?
por: Paone, Paola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_feu14vipm55ot81828e1a4hj8m